We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
(+24%)
Cap. Flow
+$1B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$120M |
| 2 |
Globe Life
GL
|
+$115M |
| 3 |
MPT
Medical Properties Trust
MPT
|
+$91.5M |
| 4 |
Arch Capital
ACGL
|
+$69.2M |
| 5 |
Amazon
AMZN
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$138M |
| 2 |
GSK
GSK
|
+$98.7M |
| 3 |
Crown Holdings
CCK
|
+$92.3M |
| 4 |
American Water Works
AWK
|
+$54M |
| 5 |
SolarEdge
SEDG
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Financials | 15.05% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Communication Services | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Pan American Silver
PAAS
$21.6B
| $1.06M | 0.01% |
30,842
+10,655
| +53% | +$344K |
|
677
Conagra Brands
CAG
$7.23B
| $1.06M | 0.01% |
29,319
+4,178
| +17% | +$152K |
|
678
AngloGold Ashanti
AU
$48.7B
| $1.06M | 0.01% |
46,817
+15,289
| +48% | +$367K |
|
679
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.65B
| $1.06M | 0.01% |
28,987
-823
| -3% | -$29.9K |
|
680
PTC
PTC
$16B
| $1.06M | 0.01% |
8,853
+8,177
| +1,210% | +$813K |
|
681
West Pharmaceutical
WST
$24.9B
| $1.05M | 0.01% |
3,720
+2
| +0.1% | +$561 |
|
682
IQVIA
IQV
$39.3B
| $1.05M | 0.01% |
5,874
+43
| +0.7% | +$7.25K |
|
683
MongoDB
MDB
$32.1B
| $1.02M | 0.01% |
2,838
+2,212
| +353% | +$618K |
|
684
Boston Scientific
BSX
$71.5B
| $1.02M | 0.01% |
28,321
+7,596
| +37% | +$274K |
|
685
MP Materials
MP
$9.1B
| $1.01M | 0.01% |
31,500
-10,000
| -24% | -$193K |
|
686
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.3B
| $1.01M | 0.01% |
13,820
+6,290
| +84% | +$430K |
|
687
Southern Company
SO
$107B
| $1M | 0.01% |
16,374
+3,409
| +26% | +$205K |
|
688
WisdomTree India Earnings Fund ETF
EPI
$2.06B
| $1M | 0.01% |
34,405
+425
| +1% | +$11.1K |
|
689
Jazz Pharmaceuticals
JAZZ
$16.7B
| $1M | 0.01% |
6,082
-1,022
| -14% | -$152K |
|
690
iShares S&P 100 ETF
OEF
$20.5B
| $997K | 0.01% |
5,809
+23
| +0.4% | +$3.76K |
|
691
Plug Power
PLUG
$3.04B
| $989K | 0.01% |
29,175
+22,675
| +349% | +$513K |
|
|
MYF
692
DELISTED
Blackrock Muni Yield Investment Fund, Inc.
MYF
| $985K | 0.01% |
70,500
+10,500
| +18% | +$144K |
|
693
iShares Global 100 ETF
IOO
$9.5B
| $981K | 0.01% |
15,614
+387
| +3% | +$23K |
|
694
Aecom
ACM
$9.75B
| $977K | 0.01% |
19,645
+8,133
| +71% | +$389K |
|
695
Globus Medical
GMED
$11.2B
| $977K | 0.01% |
14,990
+9,801
| +189% | +$563K |
|
696
iShares Cybersecurity and Tech ETF
IHAK
$1.1B
| $977K | 0.01% |
24,223
-12,892
| -35% | -$450K |
|
|
AMJ
697
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $977K | 0.01% |
70,438
-175
| -0.2% | -$2.28K |
|
698
Citi Trends
CTRN
$605M
| $975K | 0.01% |
+20,080
| New | +$683K |
|
699
Pacer Trendpilot US Large Cap ETF
PTLC
$3.37B
| $966K | 0.01% |
29,552
-2,000
| -6% | -$62.4K |
|
700
Bunge Global
BG
$20.8B
| $964K | 0.01% |
14,710
+40
| +0.3% | +$2.33K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.
- Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
- Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
- Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
- Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
- Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
- Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
- Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.
Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.